Merck & Co Inc said on Tuesday it intends to ramp up production of its top-selling vaccine Gardasil in 2023 and warned of a slowdown in revenue growth next year as demand for the therapy outpaces supply.
E-commence giant Amazon's one-day shipping is poised to pose a big threat to retailers, according to Morgan Stanley.
The S&P 500 hovered near its record high on Tuesday, lifted by upbeat earnings from drugmakers Merck and Pfizer, while a disappointing quarterly profit from Google-parent Alphabet kept the Nasdaq firmly in the negative territory.
Boeing Co Chief Executive Dennis Muilenburg, at the start of two days of testimony before U.S. lawmakers, faced tough questions on Tuesday on the crashes of two 737 MAX planes that killed 346 people and sparked calls for reforms.
Indian budget carrier IndiGo has placed an order for 300 Airbus A320neo-family jets worth at least $33 billion at recent catalog prices, handing the European planemaker what could be its biggest ever order from a single carrier.
Air Canada said on Tuesday it expects higher capacity and revenues during the last three months of 2019, after reporting lower-than-expected third-quarter profit in the wake of the grounding of Boeing Co's 737 MAX jets.
U.S. consumer confidence unexpectedly fell in October amid household concerns about the short-term outlook for business conditions and job prospects.
Pfizer Inc posted third-quarter profit well above analysts' estimates on higher sales of cancer drug Ibrance and new heart medicine Vyndaqel, encouraging the largest U.S. drugmaker to lift its earnings forecast for the year.
Sberbank has agreed to buy Gazprombank's holding stake in internet company Mail.ru as Russia's largest lender continues its transformation under Chief Executive German Gref into a banking-to-online services company.
General Motors Co on Tuesday slashed its earnings forecast for 2019, saying that a 40-day U.S. labor strike by the United Auto Workers union that brought virtually all of its North American operations to a standstill would cost it around $3 billion in profits this year.
Merck & Co Inc on Tuesday said it expected immunotherapy Keytruda to continue its market dominance as an initial treatment for advanced lung cancer as sales of the drug topped $3 billion in a quarter for the first time, beating lofty Wall Street estimates.
Tesla Inc's third-quarter revenue fell 39% in the United States, a regulatory filing showed https://www.sec.gov/ix?doc=/Archives/edgar/data/1318605/000156459019038256/tsla-10q_20190930.htm on Tuesday.
World stocks hovered near a 15-month high on Tuesday underpinned by cautious hopes over a China-U.S trade deal and expectations of another dose of policy stimulus from the Federal Reserve, with safe havens such as gold and yen on the back foot.
U.S. President Donald Trump and Chinese President Xi Jinping are expected to finalize a trade agreement on the sidelines of next month's Asia-Pacific Economic Cooperation summit in Chile, but the date is still fluid, a White House official said on Tuesday.
The U.S.-China trade war persists as an impediment to the growth of U.S. companies, even as the two countries appear close to clinching a limited agreement.